Immunotherapy more chemotherapy safer, and faster, while the effect is consistent with the effect of chemical treatment 翻译结果4复制译文编辑译文朗读译文返回顶部 immune therapy more chemical therapy is safer and more rapid, and at the same time, its effectiveness and efficacy of a chemical treatment...
(4) Conclusions: Based on current evidence, we considered that immunotherapy might not be superior to chemotherapy as a subsequent therapy for relapsed MPM. Although several studies investigated the efficacy of ICIs, targeting drugs, and chemotherapy in relapsed MPM, there was still no st...
Immunotherapy is considered a major breakthrough in the treatment of small cell lung cancer (SCLC), although its anti-tumor efficacy is limited. With a high degree of malignancy and high heterogeneity, SCLC is difficult to treat in the clinic. A new combination strategy is urgently needed to f...
Immunotherapy or chemotherapy as local therapy of urinary bladder cancer -聽which is the most effective? Report on a meta-analysis of the long-term outcome of randomized studies comparing intravesical mitomycin C versus Bacillus Calmette-Guerin for non-muscle invasive bladder cancer. Eur Urol suppl ...
- 《Cancer Immunology & Immunotherapy》 被引量: 146发表: 2012年 Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma Responders to chemotherapy had significantly longer median overall survival than non-responders (18.2 vs. 9.9 months, P = 0.02)...
Chemotherapy often generates intratumoral senescent cancer cells that strongly modify the tumor microenvironment, favoring immunosuppression and tumor growth. We discovered, through an unbiased proteomics screen, that the immune checkpoint inhibitor prog
“Patients with tumors that have TP53 mutations will receive chemotherapy and then PARP inhibitors for 2 years. Those with dMMR tumors will receive radiation treatment and then immunotherapy for 1 year. Those with MMSP [malignant melanoma of soft parts] tumors will receive radiation treatment and ...
Surgical Intervention Provides the Foundation for Exploring Immunotherapy in Glioblastoma Study Tests Guidelines for Monitoring Pancreatic Cysts The COVID-19 Pandemic Will Have Long-Term Impact on Oncology Practices Patient Perspective Should Be Part of Assessing Value in Cancer Care ...
Immunotherapy has emerged as a promising option for treating lung cancer. Compared to conventional chemotherapy, which focuses on inhibiting the process of cell division, immunotherapy aims to modulate the patient’s anti-tumor immune response, resulting in favorable survival outcome and fewer side effec...
producing TFH-like cells in EGFR-MT may result in the inefficient formation of TLS. The observed depletion of tumor-infiltrating B cells (Fig.2d) also suggests lower TLS development in EGFR-MT. Recently, B cells and TLS have been shown to be associated with responses to immunotherapy26,27,...